JCR Pharmaceuticals' Research Presentations at WORLDSymposium™ 2024 Showcase JR-141 (Pabinafusp Alfa) and Other Investigational Treatments for Lysosomal Storage Disorders | Region
HYOGO, Japan--(BUSINESS WIRE)--Feb 14, 2024--
Stay updated with breaking news from Bayley Scale. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
HYOGO, Japan--(BUSINESS WIRE)--Feb 14, 2024--
Nutrition plays an important role in cognitive development of children. Various mental assessment scales are used to measure the cognitive development of individuals.
Background Congenital heart conditions often cause developmental delays and impact neurodevelopment throughout one’s lifetime. Hence, it is crucial to analyze the impact that heart defects have on the developing brain of a child. The present cross-sectional study was undertaken given the paucity of studies on the developmental status in children with congenital heart diseases (CHDs) in central India, where we tried to evaluate and compare the prevalence of neurodevelopmental delay in individuals with different congenital cardiac disorders. The objectives of our study were, firstly, to utiliz...
Positive Data from FIREFISH Study of Evrysdi™ (risdiplam) in Infants with Type 1 Spinal Muscular Atrophy Published in The New England Journal of Medicine -- Results found that patients treated with Evrysdi at 12 months demonstrated significant improvements in survival and developmental milestones -- -- The U.S. Food and Drug Administration approved Evrysdi in August 2020 as the first and only at home SMA treatment with proven efficacy in adults, children and infants 2 months and older -- News provided by Share this article Share this article SOUTH PLAINFIELD, N.J., Feb. 24, 2021 /PRNewswire...